NYSE · CIK 0001824920
IONQ IonQ, Inc.
Insider trading from SEC Form 4. Last filing 27 d ago. Close $39.89 on Oct 9, 2026, +50% from the 52-week low and -51% from the high.
Last 90 days
Net insider value
-$90k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$90k by 1 insider
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
IONQOct 9, 2026 · close 39.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at IonQ, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 4Weak | John w Raymond director, other sell | $90k 2,407 shares | -3% | +39% from low-55% from high | |
| 33Weak | John w Raymond director, other sell | $93k 2,800 shares | -3% | +60% from low-60% from high | |
| 7Weak | Robert T. Cardillo director, other sell | $204k 5,165 shares | -4% | +124% from low-50% from high | |
| 39Weak | William J Teuber Jr director buy | $115k 3,000 shares | +47% | +110% from low-53% from high | |
| 3Weak | Gabrielle B Toledano director sell | $19k 616 shares | -6% | +73% from low-61% from high | |
| 0Weak | Kathryn K. Chou director sell | $275k 5,000 shares | -8% | +195% from low-34% from high | |
| 10Weak | Kathryn K. Chou director sell | $1.0M 20,000 shares | -25% | +188% from low-36% from high | |
| 25Weak | Rima Alameddine Chief Revenue Officer sell | $4.7M 100,000 shares | -19% | +124% from low-50% from high | |
| 39Weak | William J Teuber Jr director buy | $110k 2,000 shares | +45% | +198% from low-34% from high | |
| 17Weak | Robert T. Cardillo director, other sell | $443k 8,773 shares | -19% | +654% from low0% from high | |
| 53Moderate | Rima Alameddine Chief Revenue Officer sell | $887k 19,976 shares | -4% | +551% from low-8% from high | |
| 42Moderate | Paul T Dacier Chief Administrative Officer sell | $185k 4,175 shares | -4% | +551% from low-8% from high | |
| 61Notable | Niccolo de Masi President and CEO sell | $716k 16,120 shares | -1% | +551% from low-8% from high | |
| 47Moderate | Thomas G. Kramer Chief Financial Officer sell | $2.7M 64,578 shares | -12% | +467% from low-20% from high | |
| 53Moderate | Inder M Singh CFO & COO sell | $2.2M 50,480 shares | -90% | +470% from low-19% from high | |
| 31Weak | Thomas G. Kramer Chief Financial Officer sell | $734k 17,776 shares | -3% | +470% from low-19% from high | |
| 33Weak | Inder M Singh CFO & COO sell | $1.4M 37,090 shares | -87% | +427% from low-25% from high | |
| 42Moderate | Thomas G. Kramer Chief Financial Officer sell | $2.3M 47,478 shares | -8% | +515% from low-13% from high | |
| 29Weak | Kathryn K. Chou director sell | $293k 6,789 shares | -10% | +478% from low-18% from high | |
| 42Moderate | Thomas G. Kramer Chief Financial Officer sell | $2.1M 43,382 shares | -7% | +522% from low-12% from high | |
| 20Weak | Rima Alameddine Chief Revenue Officer sell | $2.1M 45,000 shares | -8% | +525% from low-11% from high | |
| 8Weak | Kathryn K. Chou director sell | $231k 5,000 shares | -7% | +525% from low-11% from high | |
| 47Moderate | Thomas G. Kramer Chief Financial Officer sell | $3.0M 72,000 shares | -10% | +519% from low-12% from high | |
| 45Moderate | Peter Hume Chapman Executive Chair sell | $60M 1,497,311 shares | -79% | +458% from low-21% from high | |
| 45Moderate | Peter Hume Chapman Executive Chair sell | $171M 4,491,933 shares | -113% | +432% from low-25% from high | |
| 47Moderate | Thomas G. Kramer Chief Financial Officer sell | $8.2M 216,000 shares | -23% | +432% from low-25% from high | |
| 25Weak | Rima Alameddine Chief Revenue Officer sell | $3.3M 84,976 shares | -15% | +449% from low-22% from high | |
| 31Weak | Robert T. Cardillo director sell | $405k 10,058 shares | -24% | +449% from low-22% from high | |
| 53Moderate | Peter Hume Chapman Executive Chair sell | $498k 11,965 shares | -3% | +449% from low-22% from high | |
| 30Weak | Kathryn K. Chou director sell | $1.0M 25,696 shares | -29% | +449% from low-22% from high | |
| 40Moderate | Inder M Singh CFO & COO sell | $1.7M 43,391 shares | -62% | +435% from low-24% from high | |
| 53Moderate | Thomas G. Kramer Chief Financial Officer sell | $416k 9,994 shares | -1% | +449% from low-22% from high | |
| 65Notable | Niccolo de Masi President and CEO sell | $105M 2,597,500 shares | -100% | +449% from low-22% from high | |
| 36Weak | Gabrielle B Toledano director sell | $33k 792 shares | -50% | +449% from low-22% from high | |
| 20Weak | Wendy Thomas director sell | $658k 16,696 shares | -21% | +435% from low-24% from high | |
| 56Moderate | Niccolo de Masi President and CEO sell | $392k 9,280 shares | -1% | +454% from low-22% from high | |
| 45Moderate | Rima Alameddine Chief Revenue Officer sell | $372k 20,047 shares | -3% | +159% from low-63% from high | |
| 47Moderate | Peter Hume Chapman Executive Chair sell | $224k 12,069 shares | -3% | +159% from low-63% from high | |
| 49Moderate | Thomas G. Kramer Chief Financial Officer sell | $217k 11,712 shares | -1% | +159% from low-63% from high | |
| 58Moderate | William F Scannell director buy | $2.0M 93,066 shares | +222% | +202% from low-57% from high | |
| 65Notable | Peter Hume Chapman Executive Chair sell | $37M 2,000,000 shares | -83% | +159% from low-63% from high | |
| 35Weak | Rima Alameddine Chief Revenue Officer sell | $30k 1,407 shares | -0% | +183% from low-60% from high | |
| 50Moderate | Rima Alameddine Chief Revenue Officer sell | $634k 21,337 shares | -4% | - | |
| 56Moderate | Peter Hume Chapman President and CEO sell | $390k 13,106 shares | -3% | - | |
| 51Moderate | Thomas G. Kramer Chief Financial Officer sell | $291k 9,780 shares | -1% | - | |
| 11Weak | Rima Alameddine Chief Revenue Officer sell | $406k 22,875 shares | -4% | - | |
| 7Weak | Rima Alameddine Chief Revenue Officer sell | $189k 12,000 shares | -2% | - | |
| 6Weak | Rima Alameddine Chief Revenue Officer sell | $156k 11,375 shares | -2% | - | |
| 5Weak | Rima Alameddine Chief Revenue Officer sell | $116k 9,875 shares | -2% | - | |
| 5Weak | Rima Alameddine Chief Revenue Officer sell | $106k 9,875 shares | -1% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 10, 2024 | Chapman Peter Hume Officer, Director | 14,560 0.01% of outstanding | $523k | Dec 11, 2024 | $82k |
| Dec 9, 2024 | Alameddine Rima Officer | 24,050 0.01% of outstanding | $865k | Dec 11, 2024 | $1.1M |
| Oct 28, 2024 | RIMA ALAMEDDINE & ZIAD ALAMEDDINE Officer | 22,875 0.01% of outstanding | $388k | Oct 28, 2024 | $700k |
| Oct 23, 2024 | RIMA ALAMEDDINE & ZIAD ALAMEDDINE Officer | 12,000 0.01% of outstanding | $180k | Oct 23, 2024 | $511k |
| Oct 18, 2024 | RIMA ALAMEDDINE & ZIAD ALAMEDDINE Officer | 11,375 0.01% of outstanding | $142k | Oct 18, 2024 | $355k |
| Oct 16, 2024 | RIMA ALAMEDDINE & ZIAD ALAMEDDINE Officer | 9,875 0.00% of outstanding | $104k | Oct 16, 2024 | $239k |
| Oct 11, 2024 | RIMA ALAMEDDINE & ZIAD ALAMEDDINE Officer | 9,875 0.00% of outstanding | $97k | Oct 11, 2024 | $133k |
Congressional trades
1 trade in IONQ disclosed by members of Congress under the STOCK Act. All congressional trades.
- W. Gregory SteubeHouse · R-FL · last Apr 14, 20261 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
W. Gregory Steube House · R-FL | Purchase | IONQ IonQ, Inc. Common Stock | $1,001 to $15k | Mar 18 / Apr 14 27 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Niccolo de Masi President and CEO | FTax withholding Common Stock | -16,121 | $37.09 | $598k | 1,123,426 | 27 d ago |
| Sep 11, 2026 | Inder M Singh CFO & COO | FTax withholding Common Stock | -6,272 | $37.09 | $233k | 408,614 | 27 d ago |
| Sep 11, 2026 | Paul T Dacier CAO, CLO and Secretary | FTax withholding Common Stock | -4,457 | $37.09 | $165k | 100,001 | 27 d ago |
| Sep 10, 2026 | John w Raymond director, other | SOpen-market sale Common Stock10b5-1 | -2,407 | $37.21 | $90k | 77,741 | 31 d ago |
| Mar 11, 2026 | Inder M Singh CFO & COO | FTax withholding Common Stock | -8,134 | $34.80 | $283k | 423,775 | Mar 13, 2026 |
| Mar 11, 2026 | Niccolo de Masi President and CEO | FTax withholding Common Stock | -20,785 | $34.80 | $723k | 1,155,667 | Mar 13, 2026 |
| Mar 11, 2026 | Paul T Dacier CAO, CLO and Secretary | FTax withholding Common Stock | -6,181 | $34.80 | $215k | 108,568 | Mar 13, 2026 |
| Mar 11, 2026 | Robert T. Cardillo director, other | FTax withholding Common Stock | -904 | $34.80 | $31k | 139,967 | Mar 13, 2026 |
| Mar 12, 2026 | John w Raymond director, other | SOpen-market sale Common Stock | -2,800 | $33.34 | $93k | 83,963 | Mar 13, 2026 |
| Mar 2, 2026 | Robert T. Cardillo director, other | AGrant or award Common Stock | +31,651 | $0.00 | $0 | 140,871 | Mar 4, 2026 |
| Feb 27, 2026 | William J Teuber Jr director | POpen-market purchase Common Stock | +3,000 | $38.39 | $115k | 9,413 | Feb 27, 2026 |
| Feb 26, 2026 | Robert T. Cardillo director, other | MOption exercise Common Stock10b5-1 | +2,500 | $11.24 | $28k | 117,456 | Feb 27, 2026 |
| Feb 26, 2026 | Robert T. Cardillo director, other | SOpen-market sale Common Stock10b5-1 | -5,165 | $39.44 | $204k | 112,291 | Feb 27, 2026 |
| Feb 27, 2026 | Robert T. Cardillo director, other | FTax withholding Common Stock10b5-1 | -3,071 | $39.19 | $120k | 109,220 | Feb 27, 2026 |
| Feb 26, 2026 | Robert T. Cardillo director, other | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 15,047 | Feb 27, 2026 |
| Feb 24, 2026 | Gabrielle B Toledano director | SOpen-market sale Common Stock10b5-1 | -616 | $31.00 | $19k | 9,385 | Feb 25, 2026 |
| Feb 20, 2026 | Paul T Dacier CAO, CLO and Secretary | AGrant or award Common Stock | +4,427 | $0.00 | $0 | 114,749 | Feb 20, 2026 |
| Feb 20, 2026 | Inder M Singh CFO & COO | AGrant or award Common Stock | +3,708 | $0.00 | $0 | 431,909 | Feb 20, 2026 |
| Feb 20, 2026 | Niccolo de Masi President and CEO | AGrant or award Common Stock | +11,556 | $0.00 | $0 | 1,176,452 | Feb 20, 2026 |
| Dec 22, 2025 | Kathryn K. Chou director | MOption exercise Common Stock10b5-1 | +5,000 | $4.61 | $23k | 65,839 | Dec 23, 2025 |
| Dec 22, 2025 | Kathryn K. Chou director | SOpen-market sale Common Stock10b5-1 | -5,000 | $55.00 | $275k | 60,839 | Dec 23, 2025 |
| Dec 22, 2025 | Kathryn K. Chou director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 19,900 | Dec 23, 2025 |
| Dec 11, 2025 | Paul T Dacier CAO, CLO and Secretary | FTax withholding Common Stock | -4,132 | $50.49 | $209k | 110,322 | Dec 15, 2025 |
| Dec 11, 2025 | Scott Francis Millard Chief Business Officer | FTax withholding Common Stock | -19,586 | $50.49 | $989k | 216,457 | Dec 15, 2025 |
| Dec 11, 2025 | Niccolo de Masi President and CEO | FTax withholding Common Stock | -16,290 | $50.49 | $822k | 1,164,896 | Dec 15, 2025 |
| Dec 11, 2025 | Inder M Singh CFO & COO | FTax withholding Common Stock | -12,553 | $50.49 | $634k | 428,201 | Dec 12, 2025 |
| Dec 11, 2025 | Kathryn K. Chou director | MOption exercise Common Stock10b5-1 | +20,000 | $4.61 | $92k | 80,839 | Dec 12, 2025 |
| Dec 11, 2025 | Kathryn K. Chou director | SOpen-market sale Common Stock10b5-1 | -20,000 | $51.40 | $1.0M | 60,839 | Dec 12, 2025 |
| Dec 11, 2025 | Kathryn K. Chou director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 24,900 | Dec 12, 2025 |
| Nov 20, 2025 | Rima Alameddine Chief Revenue Officer | SOpen-market sale Common Stock10b5-1 | -100,000 | $46.89 | $4.7M | 432,616 | Nov 21, 2025 |
| Nov 17, 2025 | John w Raymond director, other | AGrant or award Common Stock | +83,700 | $0.00 | $0 | 86,763 | Nov 19, 2025 |
| Nov 11, 2025 | William J Teuber Jr director | POpen-market purchase Common Stock | +2,000 | $54.82 | $110k | 6,413 | Nov 13, 2025 |
| Nov 10, 2025 | Inder M Singh CFO & COO | AGrant or award Common Stock | +274,947 | $0.00 | $0 | 440,754 | Nov 12, 2025 |
| Oct 6, 2025 | Dean P. Acosta CCA & GRO | AGrant or award Common Stock | +75,959 | $0.00 | $0 | 75,959 | Oct 8, 2025 |
| Sep 25, 2025 | John w Raymond director | AGrant or award Common Stock | +3,063 | $0.00 | $0 | 3,063 | Sep 29, 2025 |
| Sep 10, 2025 | Robert T. Cardillo director, other | AGrant or award Common Stock | +45,600 | $0.00 | $0 | 83,036 | Sep 25, 2025 |
| Sep 10, 2025 | Robert T. Cardillo director, other | AGrant or award Common Stock | +31,920 | $0.00 | $0 | 114,956 | Sep 25, 2025 |
| Sep 12, 2025 | Robert T. Cardillo director, other | MOption exercise Common Stock10b5-1 | +8,773 | $11.24 | $99k | 46,209 | Sep 16, 2025 |
| Sep 12, 2025 | Robert T. Cardillo director, other | SOpen-market sale Common Stock10b5-1 | -8,773 | $50.52 | $443k | 37,436 | Sep 16, 2025 |
| Sep 12, 2025 | Robert T. Cardillo director, other | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,773 | $0.00 | $0 | 17,547 | Sep 16, 2025 |
| Sep 11, 2025 | Rima Alameddine Chief Revenue Officer | SOpen-market sale Common Stock | -19,976 | $44.40 | $887k | 532,616 | Sep 12, 2025 |
| Sep 11, 2025 | Paul T Dacier Chief Administrative Officer | SOpen-market sale Common Stock | -4,175 | $44.40 | $185k | 114,454 | Sep 12, 2025 |
| Sep 11, 2025 | Niccolo de Masi President and CEO | SOpen-market sale Common Stock | -16,120 | $44.40 | $716k | 1,181,186 | Sep 12, 2025 |
| Sep 4, 2025 | Inder M Singh CFO and COO | AGrant or award Common Stock | +160,294 | $0.00 | $0 | 165,807 | Sep 8, 2025 |
| Sep 3, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -64,578 | $41.82 | $2.7M | 473,302 | Sep 5, 2025 |
| Aug 26, 2025 | Jim Frankola director | AGrant or award Common Stock | +4,413 | $0.00 | $0 | 4,413 | Aug 28, 2025 |
| Aug 26, 2025 | William J Teuber Jr director | AGrant or award Common Stock | +4,413 | $0.00 | $0 | 4,413 | Aug 28, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Common Stock | +33,570 | $12.93 | $434k | 39,083 | Aug 15, 2025 |
| Aug 13, 2025 | Paul T Dacier CLO and Corporate Secretary | AGrant or award Common Stock | +109,197 | $0.00 | $0 | 118,629 | Aug 15, 2025 |
| Aug 13, 2025 | Niccolo de Masi President and CEO | AGrant or award Common Stock | +485,319 | $0.00 | $0 | 1,197,306 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Common Stock | +2,050 | $5.72 | $12k | 41,133 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Common Stock | +14,860 | $13.53 | $201k | 55,993 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | SOpen-market sale Common Stock | -50,480 | $43.02 | $2.2M | 5,513 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Stock Option (right to buy)derivative | -33,570 | $12.93 | $434k | 0 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Stock Option (right to buy)derivative | -2,050 | $5.72 | $12k | 10,000 | Aug 15, 2025 |
| Aug 13, 2025 | Inder M Singh CFO & COO | MOption exercise Stock Option (right to buy)derivative | -14,860 | $13.53 | $201k | 0 | Aug 15, 2025 |
| Aug 6, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -17,776 | $41.28 | $734k | 537,880 | Aug 8, 2025 |
| Aug 1, 2025 | Inder M Singh CFO & COO | MOption exercise Common Stock10b5-1 | +10,000 | $5.72 | $57k | 42,603 | Aug 5, 2025 |
| Aug 1, 2025 | Inder M Singh CFO & COO | SOpen-market sale Common Stock10b5-1 | -37,090 | $38.28 | $1.4M | 5,513 | Aug 5, 2025 |
| Aug 1, 2025 | Inder M Singh CFO & COO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 12,050 | Aug 5, 2025 |
| Jul 23, 2025 | Gabrielle B Toledano director | AGrant or award Common Stock | +3,696 | $0.00 | $0 | 10,001 | Jul 25, 2025 |
| Jul 21, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -47,478 | $47.70 | $2.3M | 555,656 | Jul 23, 2025 |
| Jul 14, 2025 | Paul T Dacier CLO and Corporate Secretary | AGrant or award Common Stock | +9,432 | $0.00 | $0 | 9,432 | Jul 16, 2025 |
| Jul 11, 2025 | Kathryn K. Chou director | SOpen-market sale Common Stock10b5-1 | -6,789 | $43.14 | $293k | 60,839 | Jul 15, 2025 |
| Jul 8, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -43,382 | $47.73 | $2.1M | 603,134 | Jul 10, 2025 |
| Jul 7, 2025 | Rima Alameddine Chief Revenue Officer | MOption exercise Common Stock10b5-1 | +45,000 | $4.65 | $209k | 597,592 | Jul 7, 2025 |
| Jul 7, 2025 | Kathryn K. Chou director | MOption exercise Common Stock10b5-1 | +5,000 | $4.61 | $23k | 72,628 | Jul 7, 2025 |
| Jul 2, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -72,000 | $42.26 | $3.0M | 646,516 | Jul 7, 2025 |
| Jul 7, 2025 | Rima Alameddine Chief Revenue Officer | SOpen-market sale Common Stock10b5-1 | -45,000 | $46.18 | $2.1M | 552,592 | Jul 7, 2025 |
| Jul 7, 2025 | Kathryn K. Chou director | SOpen-market sale Common Stock10b5-1 | -5,000 | $46.18 | $231k | 67,628 | Jul 7, 2025 |
| Jul 7, 2025 | Rima Alameddine Chief Revenue Officer | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -45,000 | $0.00 | $0 | 928,000 | Jul 7, 2025 |
| Jul 7, 2025 | Kathryn K. Chou director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 44,900 | Jul 7, 2025 |
| Jun 20, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Common Stock10b5-1 | +1,497,311 | $0.13 | $200k | 1,887,640 | Jun 20, 2025 |
| Jun 20, 2025 | Peter Hume Chapman Executive Chair | SOpen-market sale Common Stock10b5-1 | -1,497,311 | $39.93 | $60M | 390,329 | Jun 20, 2025 |
| Jun 20, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,497,311 | $0.13 | $200k | 107,661 | Jun 20, 2025 |
| Jun 18, 2025 | Robert T. Cardillo director | AGrant or award Common Stock | +5,513 | $0.00 | $0 | 37,436 | Jun 18, 2025 |
| Jun 18, 2025 | Kathryn K. Chou director | AGrant or award Common Stock | +5,513 | $0.00 | $0 | 67,628 | Jun 18, 2025 |
| Jun 18, 2025 | Inder M Singh CFO & COO | AGrant or award Common Stock | +5,513 | $0.00 | $0 | 32,603 | Jun 18, 2025 |
| Jun 18, 2025 | Gabrielle B Toledano director | AGrant or award Common Stock | +5,513 | $0.00 | $0 | 6,305 | Jun 18, 2025 |
| Jun 18, 2025 | William F Scannell director | AGrant or award Common Stock | +5,513 | $0.00 | $0 | 140,560 | Jun 18, 2025 |
| Jun 16, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Common Stock10b5-1 | +3,581,193 | $0.13 | $478k | 3,971,522 | Jun 18, 2025 |
| Jun 16, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -216,000 | $38.11 | $8.2M | 718,516 | Jun 18, 2025 |
| Jun 16, 2025 | Peter Hume Chapman Executive Chair | SOpen-market sale Common Stock10b5-1 | -3,581,193 | $38.13 | $137M | 390,329 | Jun 18, 2025 |
| Jun 17, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Common Stock10b5-1 | +910,740 | $0.13 | $121k | 1,301,069 | Jun 18, 2025 |
| Jun 17, 2025 | Peter Hume Chapman Executive Chair | SOpen-market sale Common Stock10b5-1 | -910,740 | $37.78 | $34M | 390,329 | Jun 18, 2025 |
| Jun 16, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -3,581,193 | $0.13 | $478k | 2,515,712 | Jun 18, 2025 |
| Jun 17, 2025 | Peter Hume Chapman Executive Chair | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -910,740 | $0.13 | $121k | 1,604,972 | Jun 18, 2025 |
| Jun 12, 2025 | Inder M Singh CFO & COO | MOption exercise Common Stock10b5-1 | +10,000 | $5.72 | $57k | 70,481 | Jun 13, 2025 |
| Jun 11, 2025 | Gabrielle B Toledano director | SOpen-market sale Common Stock10b5-1 | -792 | $41.50 | $33k | 792 | Jun 13, 2025 |
| Jun 12, 2025 | Wendy Thomas director | MOption exercise Common Stock10b5-1 | +5,000 | $4.62 | $23k | 77,841 | Jun 13, 2025 |
| Jun 11, 2025 | Rima Alameddine Chief Revenue Officer | SOpen-market sale Common Stock10b5-1 | -19,976 | $41.60 | $831k | 552,592 | Jun 13, 2025 |
| Jun 11, 2025 | Niccolo de Masi President and CEO | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -2,597,500 | $40.34 | $105M | 0 | Jun 13, 2025 |
| Jun 11, 2025 | Thomas G. Kramer Chief Financial Officer | SOpen-market sale Common Stock | -9,994 | $41.60 | $416k | 934,516 | Jun 13, 2025 |
| Jun 11, 2025 | Robert T. Cardillo director | SOpen-market sale Common Stock10b5-1 | -10,058 | $40.22 | $405k | 31,923 | Jun 13, 2025 |
| Jun 11, 2025 | Peter Hume Chapman Executive Chair | SOpen-market sale Common Stock | -11,965 | $41.60 | $498k | 390,329 | Jun 13, 2025 |
| Jun 11, 2025 | Kathryn K. Chou director | MOption exercise Common Stock10b5-1 | +14,000 | $4.61 | $65k | 87,811 | Jun 13, 2025 |
| Jun 13, 2025 | Rima Alameddine Chief Revenue Officer | MOption exercise Common Stock10b5-1 | +65,000 | $4.65 | $302k | 617,592 | Jun 13, 2025 |
| Jun 12, 2025 | Inder M Singh CFO & COO | SOpen-market sale Common Stock10b5-1 | -43,391 | $39.18 | $1.7M | 27,090 | Jun 13, 2025 |
| Jun 12, 2025 | Wendy Thomas director | SOpen-market sale Common Stock10b5-1 | -16,696 | $39.43 | $658k | 61,145 | Jun 13, 2025 |
| Jun 11, 2025 | Kathryn K. Chou director | SOpen-market sale Common Stock10b5-1 | -25,696 | $40.46 | $1.0M | 62,115 | Jun 13, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Dean P. AcostaCCA & GRO
- Rima AlameddineChief Revenue Officer
- Robert T. Cardillodirector, other
- Peter Hume ChapmanExecutive Chair
- Kathryn K. Choudirector
- Paul T DacierCAO, CLO and Secretary
- Jim Frankoladirector
- Thomas G. KramerChief Financial Officer
- Scott Francis MillardChief Business Officer
- John w Raymonddirector, other
- William F Scannellofficer, director
- Inder M SinghCFO & COO
- William J Teuber Jrdirector
- Gabrielle B Toledanodirector
- Wendy Thomasdirector
- Niccolo de MasiPresident and CEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.